Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer (Osteoporosis)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00957606|
Recruitment Status : Unknown
Verified April 2011 by Odense University Hospital.
Recruitment status was: Recruiting
First Posted : August 12, 2009
Last Update Posted : April 13, 2011
The purpose of this study is
- to determine the rate of osteoporosis among patients with advanced prostate cancer.
- to propose an algorithm for early detection of patients with advanced prostate cancer who are at risk of developing osteoporosis.
|Condition or disease||Intervention/treatment||Phase|
|Prostate Cancer Androgen Deprivation Therapy Osteoporosis||Procedure: blood sampling, DXA-scan, bone scintigraphy||Phase 3|
Patients with advanced prostate cancer are included at the initiating of androgen deprivation therapy.
The patients are followed for 2 years after inclusion with blood sampling, DXA-scan, questionnaire, bone scintigraphy.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer: Symptoms, Risc Factors, and Prevention|
|Study Start Date :||August 2009|
|Estimated Primary Completion Date :||March 2013|
|Estimated Study Completion Date :||September 2013|
- Procedure: blood sampling, DXA-scan, bone scintigraphy
Blood sampling 5 times DXA-scan 5 times Bone scintigraphy 3 times
- Osteoporosis, either T-score < -2,5 or osteoporosis fracture [ Time Frame: 2½ years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00957606
|Contact: Mads H Poulsen, MD||Mads.Poulsen@ouh.regionsyddanmark.dk|
|Contact: Steen Walter, MD, DMSci, Professor|
|Department of Urology, Odense University Hospital||Recruiting|
|Odense, Denmark, 5000|
|Contact: Mads H Poulsen, MD Mads.Poulsen@ouh.regionsyddanmark.dk|
|Contact: Steen Walter|
|Department of Urology, Roskilde Hospital||Recruiting|
|Roskilde, Denmark, 4000|
|Contact: Claus Dahl, MD|
|Principal Investigator:||Mads H Poulsen, MD||Department of Urology, Odense University Hospital, Denmark|
|Study Chair:||Steen Walter, MD, DMSci, Professor||Department of Urology, Odense University Hospital, Denmark|
|Study Chair:||Morten MF Nielsen, MD||Department of Endocrinology, Odense University Hospital, Denmark|
|Study Chair:||Kim Brixen, MD, PhD, Professor||Department of Endocrinology, Odense University Hospital, Denmark|
|Study Chair:||Claus Dahl, MD||Department of Urology, Roskilde Hospital, Denmark|
|Study Chair:||Peter Eskildsen, MD, DMSci||Department of Endocrinology, Køge Hospital, Denmark|
|Study Chair:||Oke Gerke, PhD||University of Southern Denmark|
|Study Chair:||Bo Abrahamsen, MD, PhD, Professor||Faculty of Health Sciences, University of Southern Denmark, Denmark|